REGN
REGENERON PHARMACEUTICALS, INC.
Pharmaceutical Preparations- 売上
- $14.3bn
- 時価総額
- $67.8bn
株価 $738.34 · 100株 7万円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $13.1bn | $14.2bn | $14.3bn |
| 成長率 | — | 8.3% | 1.0% |
| 総利益 | $12.7bn | $13.8bn | $13.9bn |
| 総利益率 | 96.9% | 97.2% | 97.2% |
| 販管費 | $2.6bn | $3.0bn | $2.7bn |
| 販管費率 | 20.1% | 20.8% | 18.8% |
| 営利 | $4.0bn | $4.0bn | $3.6bn |
| 営利率 | 30.9% | 28.1% | 24.9% |
| 純利益 | $4.0bn | $4.4bn | $4.5bn |
| PBR | 2.6 | 2.3 | 2.2 |
| PSR | 5.2 | 4.8 | 4.7 |
| PGPR | 5.3 | 4.9 | 4.9 |
| PER | 17 | 15 | 15 |
| ﾈｯﾄｷｬｯｼｭ | $27m | ▲$216m | $412m |
| EV/EBITDA | 15.2 | 15.2 | 16.3 |
| Rule of 40 | — | 36% | 26% |
| セールス効率 | — | 336% | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）